Catalysts for Igalmi
18 tracked
Apr 30, 2026
phase 2 completion
Wannan Medical College First Affiliated Hospital — dexmedetomidine (Phase II Trial Completion)
dexmedetomidine
→
Apr 30, 2026
phase 2 completion
Smt.B.K.Shah Medical Institute & Research Centre & Dhiraj Hospital — dexmedetomidine (Phase II Trial Completion)
dexmedetomidine
→
Apr 30, 2026
phase 2 completion
Gandhi Medical College & Hospital — dexmedetomidine (Phase II Trial Completion)
dexmedetomidine
→
Apr 30, 2026
phase 0 trial completion
Funing County People's Hospital — dexmedetomidine (Phase 0 Trial Completion)
dexmedetomidine
→
Apr 30, 2026
phase 0 trial completion
Affiliated Hospital of Xuzhou Medical University — dexmedetomidine (Phase 0 Trial Completion)
dexmedetomidine
→
Apr 30, 2026
phase 0 trial completion
Affiliated Hospital of Xuzhou Medical University — dexmedetomidine (Phase 0 Trial Completion)
dexmedetomidine
→
Apr 30, 2026
phase 0 trial completion
Civil Aviation General Hospital — dexmedetomidine (Phase 0 Trial Completion)
dexmedetomidine
→
Apr 30, 2026
phase 0 trial completion
Affiliated Hospital of Xuzhou Medical University — dexmedetomidine (Phase 0 Trial Completion)
dexmedetomidine
→
Apr 30, 2026
phase 0 trial completion
Ruijin Hospital — dexmedetomidine (Phase 0 Trial Completion)
dexmedetomidine
→
Apr 30, 2026
phase 0 trial completion
Kunming Yan'an Hospital — dexmedetomidine (Phase 0 Trial Completion)
dexmedetomidine
→
Apr 28, 2026
phase 2 initiation
SRM Medical College Hospital and Research Centre — dexmedetomidine (Phase II Trial Initiation)
dexmedetomidine
→
Apr 26, 2026
phase 2 3 completion
Kasturba Medical College — dexmedetomidine (Phase II/III Trial Completion)
dexmedetomidine
→
Apr 26, 2026
phase 2 completion
All India Institute of Medical Sciences Bibinagar — dexmedetomidine (Phase II Trial Completion)
dexmedetomidine
→
Apr 25, 2026
phase 2 completion
Jawaharlal Nehru Medical College — dexmedetomidine (Phase II Trial Completion)
dexmedetomidine
→
Apr 25, 2026
phase 2 completion
Jawaharlal Nehru Medical College Ajmer — dexmedetomidine (Phase II Trial Completion)
dexmedetomidine
→
Nov 19, 2025
approval
IGALMI (DEXMEDETOMIDINE HYDROCHLORIDE) — FDA approval
dexmedetomidine
→
Oct 24, 2022
approval
IGALMI (DEXMEDETOMIDINE HYDROCHLORIDE) — FDA approval
dexmedetomidine
→
Apr 5, 2022
approval
IGALMI (DEXMEDETOMIDINE HYDROCHLORIDE) — FDA approval
dexmedetomidine
→